1. Home
  2. Labeler Index
  3. Major Pharmaceuticals
  4. 0904-7459
  5. NDC Package Code: 0904-7459-53 Atovaquone

NDC Package 0904-7459-53 Atovaquone

Atovaquone Oral Suspension Suspension Oral - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
0904-7459-53
Package Description:
7 TRAY in 1 CASE / 6 CUP, UNIT-DOSE in 1 TRAY / 5 mL in 1 CUP, UNIT-DOSE
Product Code:
0904-7459
Proprietary Name:
Atovaquone
Non-Proprietary Name:
Atovaquone Oral Suspension
Substance Name:
Atovaquone
Usage Information:
Atovaquone is used to prevent or treat a serious lung infection called Pneumocystis pneumonia (PCP). This medication helps to stop infection symptoms such as fever, cough, tiredness, and shortness of breath.
11-Digit NDC Billing Format:
00904745953
Billing Unit:
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
NDC to RxNorm Crosswalk:
Product Type:
Human Prescription Drug
Labeler Name:
Major Pharmaceuticals
Dosage Form:
Suspension - A liquid1 dosage form that contains solid particles dispersed in a liquid vehicle.
Administration Route(s):
Oral - Administration to or by way of the mouth.
Active Ingredient(s):
ATOVAQUONE 750 mg/5mL
Pharmacologic Class(es):
Sample Package:
No
FDA Application Number:
ANDA214272
Marketing Category:
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date:
07-08-2024
Listing Expiration Date:
12-31-2025
Exclude Flag:
N
Code Structure:

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Other Product Packages

The following packages are also available for this product:

NDC Package CodePackage Description
0904-7459-253 TRAY in 1 CASE / 6 CUP, UNIT-DOSE in 1 TRAY / 5 mL in 1 CUP, UNIT-DOSE
0904-7459-415 mL in 1 CUP, UNIT-DOSE

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 0904-7459-53?

The NDC Packaged Code 0904-7459-53 is assigned to a package of 7 tray in 1 case / 6 cup, unit-dose in 1 tray / 5 ml in 1 cup, unit-dose of Atovaquone, a human prescription drug labeled by Major Pharmaceuticals. The product's dosage form is suspension and is administered via oral form.

Is NDC 0904-7459 included in the NDC Directory?

Yes, Atovaquone with product code 0904-7459 is active and included in the NDC Directory. The product was first marketed by Major Pharmaceuticals on July 08, 2024 and its listing in the NDC Directory is set to expire on December 31, 2025 if the product is not updated or renewed by the manufacturer.

What is the NDC billing unit for package 0904-7459-53?

The contents of this package are billed per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.

What is the 11-digit format for NDC 0904-7459-53?

The 11-digit format is 00904745953. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 4-4-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
4-4-20904-7459-535-4-200904-7459-53